G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma.
Lam MSY, Reales-Calderon JA, Ow JR, Aw JJY, Tan D, Vijayakumar R, Ceccarello E, Tabaglio T, Lim YT, Chien WL, Lai F, Tanoto AT, Chen Q, Sobota RM, Adriani G, Bertoletti A, Guccione E, Pavesi A.
Lam MSY, et al.
Nat Commun. 2023 Feb 2;14(1):563. doi: 10.1038/s41467-023-36160-5.
Nat Commun. 2023.
PMID: 36732506
Free PMC article.